TFA Therapeutics, Inc. (RAJAF) stock
RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$9.18+0.00 (0.00%)
Close on Oct 16, 2026Market cap –P/E –Yield –
TFA Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
TFA Therapeutics's operating margin for the twelve months ending Dec 31, 2023 was 25.8%. For fiscal 2025 it was -11.3%, against -14.7% the year before. The highest annual figure on record is 25.8% in fiscal 2023.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -11.3% | +3.3 |
| FY2024 | Dec 31, 2024 | -14.7% | −40.5 |
| FY2023 | Dec 31, 2023 | 25.8% | +804.6 |
| FY2022 | Dec 31, 2022 | -778.8% | −765.2 |
| FY2021 | Dec 31, 2021 | -13.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | 38.2% | – |
See a number that looks wrong?